• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Ascendis Pharma A/S - Ordinary Share (NQ:ASND)

229.27 +4.27 (+1.90%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 622,763
Open 224.21
Bid (Size) 90.53 (100)
Ask (Size) 357.04 (200)
Prev. Close 225.00
Today's Range 222.02 - 229.59
52wk Range 150.89 - 250.74
Shares Outstanding 57,152,295
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Ascendis Pharma Completes Strategic Trifecta with U.S. Launch of YUVIWEL and Seven-Year Orphan Exclusivity
April 13, 2026
In a move that signals a transformative shift from a clinical-stage biotech to a commercial-market leader, Ascendis Pharma (NASDAQ: ASND) officially launched its third major product, YUVIWEL... 
Via MarketMinute
Topics Economy
News headline image
Agriculture Stock Up 53% Draws $12 Million Bet. Here's What Long-Term Investors Should Know ↗
March 20, 2026
This agribusiness firm delivers grain, renewables, and plant nutrient solutions to commercial and industrial clients worldwide. 
Via The Motley Fool
Topics Regulatory Compliance

Performance

YTD
+7.5%
+7.5%
1 Month
+3.8%
+3.8%
3 Month
-2.6%
-2.6%
6 Month
+13.5%
+13.5%
1 Year
+42.9%
+42.9%

More News

Read More
News headline image
Ascendis (ASND) Q4 2025 Earnings Call Transcript ↗
February 23, 2026
Via The Motley Fool
Topics Earnings
Ascendis Pharma (NASDAQ:ASND) Shares Drop After Q4 Earnings Miss on Wider-Than-Expected Loss ↗
February 11, 2026
Via Chartmill
Topics Earnings
News headline image
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Celcuity Stock Soars 700% in a Year as One Investor's $17 Million Buy Helps Create Top Two Position ↗
February 22, 2026
Via The Motley Fool
News headline image
Apogee Shares Up Nearly 100% in 12 Months, and This $62 Million Buy Signals Ongoing Conviction ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
ASCENDIS PHARMA A/S - ADR (NASDAQ:ASND) Combines Minervini Trend Template with High Growth Momentum ↗
January 28, 2026
Via Chartmill
News headline image
Earnings Scheduled For November 12, 2025 ↗
November 12, 2025
Via Benzinga
News headline image
A Look Ahead: Ascendis Pharma's Earnings Forecast ↗
November 11, 2025
Via Benzinga
News headline image
$80 Million Arcellx Sale Follows Steep Stock Drop as Rival Drug Emerges ↗
February 22, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Ascendis Pharma (ASND) Q4 2025 Earnings Transcript ↗
February 11, 2026
Via The Motley Fool
News headline image
Ascendis Pharma (NASDAQ:ASND) Passes Minervini's Trend Template and High Growth Momentum Scan ↗
December 25, 2025
Via Chartmill
News headline image
Why Dyne Therapeutics Stock Was Crushing it This Week ↗
November 21, 2025
Via The Motley Fool
Topics Artificial Intelligence
News headline image
European ADRs Navigate Choppy Waters: Pharma Sector Shows Resilience Amidst Broader Market Volatility
November 19, 2025
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
News headline image
Ascendis (ASND) Q3 2025 Earnings Call Transcript ↗
November 13, 2025
Via The Motley Fool
Topics Earnings
News headline image
Ascendis Pharma Likely To Report Narrower Q3 Loss; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
November 12, 2025
Via Benzinga
News headline image
Here's How Much You Would Have Made Owning Ascendis Pharma Stock In The Last 10 Years ↗
October 29, 2025
Via Benzinga
News headline image
Looking Into Ascendis Pharma AS's Recent Short Interest ↗
October 21, 2025
Via Benzinga
News headline image
Ascendis Pharma A/S - ADR (NASDAQ:ASND) Shows Strong Growth Momentum in Technical and Fundamental Analysis ↗
October 14, 2025
Via Chartmill
News headline image
What Does the Market Think About Ascendis Pharma AS? ↗
September 29, 2025
Via Benzinga
News headline image
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today ↗
September 25, 2025
Via Benzinga
News headline image
PTC Therapeutics Could Challenge BioMarin For Metabolic Disorder Treatment ↗
September 08, 2025
Via Benzinga
News headline image
$100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth This Much Today ↗
September 08, 2025
Via Benzinga
News headline image
Here's How Much $100 Invested In Ascendis Pharma 10 Years Ago Would Be Worth Today ↗
September 04, 2025
Via Benzinga

Frequently Asked Questions

Is Ascendis Pharma A/S - Ordinary Share publicly traded?
Yes, Ascendis Pharma A/S - Ordinary Share is publicly traded.
What exchange does Ascendis Pharma A/S - Ordinary Share trade on?
Ascendis Pharma A/S - Ordinary Share trades on the Nasdaq Stock Market
What is the ticker symbol for Ascendis Pharma A/S - Ordinary Share?
The ticker symbol for Ascendis Pharma A/S - Ordinary Share is ASND on the Nasdaq Stock Market
What is the current price of Ascendis Pharma A/S - Ordinary Share?
The current price of Ascendis Pharma A/S - Ordinary Share is 229.27
When was Ascendis Pharma A/S - Ordinary Share last traded?
The last trade of Ascendis Pharma A/S - Ordinary Share was at 04/24/26 04:00 PM ET
What is the market capitalization of Ascendis Pharma A/S - Ordinary Share?
The market capitalization of Ascendis Pharma A/S - Ordinary Share is 13.10B
How many shares of Ascendis Pharma A/S - Ordinary Share are outstanding?
Ascendis Pharma A/S - Ordinary Share has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap